Lansdale, PA, United States of America

Scott Gulian


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator Spotlight: Scott Gulian

Introduction

Scott Gulian, an inventor based in Lansdale, PA, has made significant contributions to the field of film coating technology. He is recognized for his innovative patent, which aims to enhance the performance of oral dosage forms, such as compressed tablets.

Latest Patents

Gulian holds one patent titled "Film coatings containing fine particle size detackifiers and substrates coated therewith." This invention focuses on film coating compositions designed for oral dosage forms, incorporating fine particle size detackifiers. The patented technology allows these film coatings to be applied directly to substrates or subsequent to a subcoat application. The use of polymers like polyvinyl alcohol or its copolymers is a key aspect of this innovation. Furthermore, it describes aqueous suspensions of the film coatings, alongside methods for their application and the resulting coated substrates.

Career Highlights

Scott Gulian works with Bpsi Holdings, Inc., where he is involved in pioneering advancements in coating technologies. His expertise and dedication have positioned him as a valuable asset within his organization, contributing to various product developments aimed at improving user experience and product efficacy.

Collaborations

Throughout his career, Gulian has collaborated with notable colleagues including Thomas P Farrell and Jason Teckoe. Their combined efforts emphasize teamwork and innovation within the framework of film coating technologies, pushing the boundaries of what is possible in oral dosage formulations.

Conclusion

Scott Gulian stands out as a dedicated inventor in the area of film coatings, showcasing a commitment to developing practical solutions for the pharmaceutical industry. His work at Bpsi Holdings, Inc., and his groundbreaking patent illustrate the importance of innovation in enhancing the efficiency and functionality of oral dosage forms.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…